| Sign In to gain access to subscriptions and/or personal tools. |
Disopyramide: Six Years' ExperienceCardiovascular-Renal Clinical Research, G. D. Searle & Co., Skokie, Illinois
Duke Hospital, Duke University Medical Center, Durham, North Carolina Since its approval by the FDA six years ago, oral disopyramide has earned a recognized role in the treatment of ventricular arrhythmias. During this time, clinical experience has refined our knowledge of this agent, allowing revision of dosing guidelines and better selection of patients. This review explores the recent therapeutic experience with disopyramide.
Angiology, Vol. 34, No. 6,
367-374 (1983) |
|||